NAD+ and 5-Amino-1MQ have carved out an interesting place in the peptide and longevity research world, where the focus is shifting toward understanding the body’s energy systems, metabolism, and cellular function. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every living cell, playing a critical role in energy production, cellular repair, and metabolic processes. As NAD+ levels can change with age and other factors, researchers are investigating its potential role in healthy aging, mitochondrial function, and cellular resilience. Although NAD+ is often discussed in peptide communities, it is not a peptide itself. It has become a popular topic among people exploring the science of energy, recovery, and longevity, even as researchers continue working to establish which approaches offer meaningful benefits in humans. 5-Amino-1MQ brings a different angle to the conversation. Unlike NAD+, it is a small-molecule research compound that targets NNMT, an enzyme involved in cellular metabolism and the regulation of certain metabolic pathways. Early preclinical research has sparked interest in its potential effects on fat metabolism and body composition, making it a frequent topic in discussions about next-generation metabolic research. However, much of the evidence remains preclinical, and its safety and effectiveness in humans have not been established. Together, NAD+ and 5-Amino-1MQ represent two distinct directions in the broader research world: one exploring cellular energy and repair, the other investigating metabolic regulation. Their popularity reflects a growing interest in understanding the body at a deeper level—but the science, not the hype, must ultimately determine their place in the future of longevity and metabolic health.